Curriculum Vitae. Banke Agarwal, MD

Curriculum Vitae Banke Agarwal, MD EDUCATION AND TRAINING 1981-1983 1983-1989 1989-1992 1992-1993 1993-1996 1996-1999 1999-2000 2000 Pre-medical, D...
1 downloads 0 Views 40KB Size
Curriculum Vitae

Banke Agarwal, MD

EDUCATION AND TRAINING 1981-1983 1983-1989 1989-1992 1992-1993 1993-1996 1996-1999 1999-2000 2000

Pre-medical, DAV College, Chandigarh, India MBBS, Jawaharlal Institute of Post-graduate Medical Education and Research, Pondicherry, India MD, Jawaharlal Institute of Post-graduate Medical Education and Research, Pondicherry, India Senior Resident, Jawaharlal Institute of Post-graduate, Medical Education and Research, Pondicherry, India Resident, St. Luke’s-Roosevelt Hospital Center, Columbia University New York, NY Fellow in Gastroenterology, St. Luke’s-Roosevelt Hospital Center, Columbia University, New York, NY Advanced fellow in Gastrointestinal Endoscopy, Beth Israel Deaconess, Medical Center, Harvard University, Boston, MA Visiting fellow (Endoscopic Ultrasound), Academic Medical Center, Amsterdam, The Netherlands

BOARD CERTIFICATION AND LICENSURE BOARD CERTIFICATION National Board of Medical Examiners Diplomate American Board of Internal Medicine Diplomate in Internal Medicine Diplomate in Gastroenterology LICENSURE New Jersey Board of Medical Examiners Texas State Board of Medical Examiners Missouri State Board of Registration for the Healing Arts

CURRENT POSITION AND ADDRESS Associate Professor of Internal Medicine Director, Therapeutic Endoscopy Division of Gastroenterology and Hepatology Saint Louis University School of Medicine Division of Gastroenterology and Hepatology 3635 Vista Avenue, FDT 9 South

Banke Agarwal, M.D. St. Louis, MO 63110-0250 P: 314-577-8764 F: 314-577-8125 E-Mail: [email protected]

2

PREVIOUS PROFESSIONAL EXPERIENCE 1999-2000 2000-2002 2002-2006

2006 -

Instructor, Internal Medicine, Division of Gastroenterology, Harvard Medical School, Boston, MA Assistant Professor of Medicine, Gastrointestinal Medicine and Nutrition, MD Anderson Cancer Center, Houston, TX Assistant Professor of Internal Medicine, Division of Gastroenterology and Hepatology, Director of Therapeutic Endoscopy, Saint Louis University School of Medicine, St. Louis, MO Associate Professor of Internal Medicine (with tenure), Division of Gastroenterology and Hepatology, Director of Therapeutic Endoscopy, Saint Louis University, St. Louis, MO

CLINICAL STAFF APPOINTMENT: Saint Louis University School of Medicine St. Mary’s Health Center Missouri Baptist Medical Center PROFESSIONAL SOCIETY MEMBERSHIPS: American Gastroenterological Association American Society of Gastrointestinal Endoscopists American Association for Cancer Research HONORARY SOCIETIES, HONORS AND AWARDS 1987 1998 1999 2005 2005 2005 20052006 2006 2006 20072007

MOH Hassan Kuthoos Marikar Award for Best graduate in Cardiology by the Government of India, Ministry of Health. American Gastroenterological Association’s (AGA) Young Clinician Award. Charles Flood Research Prize for outstanding basic research. Awarded by College of Physicians and Surgeons, Columbia University, New York. Marquis Who’s Who in America, Diamond Anniversary Edition, 2005 Best Doctors in America, 2005 Research Excellence in Gastrointestinal and Liver diseases (REGAL) Award Member, Annual scientific program committee, American Society for Gastrointestinal Endoscopy Marquis Who’s Who in America, 61st Edition, 2006 Listed in Consumer Research Council’s “America’s Top Physicians” Best Doctors in America, 2006 Vice-Chair, UGI section, Annual Scientific Program Committee, American Society for Gastrointestinal Endoscopy. Best Doctors in America, 2007

Banke Agarwal, M.D. Listed in Consumer Research Council’s “America’s Top Physicians 3 Marquis Who’s Who in America, 62st Edition, 2007 Marquis Who’s Who in Science and Engineering 2007 Marquis Who’s Who in the World 2007, 25th Anniversary Edition

2007 2007 2007 2007

PROFESIONAL SERVICES REVIEWER FOR SCIENTIFIC JOURNALS: American Journal of Gastroenterology Gastrointestinal Endoscopy Clinical Cancer Research Journal of Clinical Gastroenterology Digestive Diseases and Sciences REVIEWER FOR GRANTING AGENCIES: 2004-pres. 2004-pres.

Italian Association for Cancer Research (AIRC) Dutch Cancer Society

CONFERENCE COURSE DIRECTOR: 2002 2003 2004 2005 2005 2006 2006 2006-07

2007

2008

“Gastrointestinal cancers: Integrating recent advances into clinical practice,” The Ritz-Carlton Hotel, St. Louis, MO, October 26, 2002. “Gastrointestinal cancers: An update on advances in diagnosis and management,” The Ritz-Carlton Hotel, St. Louis, MO, November 8, 2003. “Gastrointestinal cancers: An update on advances in diagnosis and management,” Chase Park Plaza, St. Louis, MO, October 2, 2004. “Gastrointestinal cancers: Integrating recent advances into clinical practice,” The Ritz-Carlton Hotel, St. Louis, MO, October 1, 2005. Controversies and Consensus in Gastrointestinal bleeding. Tony’s Restaurant, St. Louis, MO, August 18, 2005 Imaging in patients with pancreatobiliary disorders: MRCP/ERCP/EUS. Tony’s Restaurant, St. Louis, MO. April 5, 2006 “Gastrointestinal cancers: Integrating recent advances into clinical practice,” The Ritz-Carlton Hotel, St. Louis, MO, October 7, 2006. Course director for ‘Dinner Debate Series’: a series of four debates during this academic year on following topics of clinical interest in gastroenterology. Acid Peptic Disorders August 2006 Diarrhaeal Disorders November 7, 2006 Benign Pancreatobiliary disorders February 15, 2007 Non-Alcoholic Fatty Liver Disease April 25, 2007 “Gastrointestinal cancers: Integrating recent advances into clinical practice,” The Ritz-Carlton Hotel, St. Louis, MO, September, 2007 Co-sponsored by American Society for Gastrointestinal Endosscopy (ASGE and Saint Louis University School of Medicine. (www.gicancers.org). Dinner debate titled “Optimizing the use of ERCP techniques for best patient outcomes” April 24, 2008 at Tony’s restaurant, St Louis, MO. Sponsored by Saint Louis Endoscopy Society and Saint Louis University.

2008

Banke Agarwal, M.D. “Gastrointestinal cancers: Integrating recent advances into clinical practice,” 4 The Ritz-Carlton Hotel, St. Louis, MO, September, 2008 Co-sponsored by American Society for Gastrointestinal Endosscopy (ASGE and Saint Louis University School of Medicine. (www.gicancers.org).

RESEARCH SUPPORT 1.

Institute for Science and Health. “Immunohistochemical panel of markers to aid in early diagnosis of pancreatic cancers”; principal investigator, Banke Agarwal, M.D., 8/16/068/15/07; $30,000.

TRAVEL GRANTS 1. North American Conference of Gastroenterology Fellows, sponsored by American College of Gastroenterology (ACG), Tampa Florida, March 1997. 2. Methodologies in Health Care Outcomes in Gastroenterology.- Introductory and advanced workshop symposia. Organized by University of Illinois, Chicago in Philadelphia, PA, 1998. 3. North American Conference of Gastroenterology Fellows, sponsored by American College of Gastroenterology (ACG), Tampa, FL, 1998. 4. Young Investigator’s Conference. Organized by American Society of Gastrointestinal endoscopists (ASGE) and American Gastroenterology Association (AGA), Santa Monica, CA, 1998. 5. American Gastroenterology Association (AGA) World Congress of Gastroenterology in Vienna, Austria, 1998. 6. Methodologies in Health Care Outcomes in Gastroenterology. Introductory and advanced workshop symposia. Organized by University of Illinois, Chicago in Tampa, FL, 1999. 7. Young Investigator’s Conference in Atlanta, GA. Organized by American Society of Gastrointestinal Endoscopists (ASGE) and American Gastroenterology Association (AGA), Atlanta, GA 1999. 8. Gastro 99. Jointly organized by the American College of Gastroenterology (ACG), Canadian Association of Gastroenterology (CAG) and the Pan-American Society of Gastroenterology, Vancouver, Canada, 1999. 9. Young Investigator’s Conference. Organized by American Society of Gastrointestinal Endoscopists (ASGE) and American Gastroenterology Association (AGA), in La Jolla, CA, 2000.

BIBLIOGRAPHY

Banke Agarwal, M.D. Publications:

5

Original, Basic, and Clinical Investigation 1. Moss SF, Agarwal B, Arber N, Guan RJ, Krajewska M, Krajewski S, Reed JC, Holt PR. Increased intestinal Bak expression results in Apoptosis. Biochemical and Biophysical Research Communications 1996;223:199-203. 2. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996;38:498-501. 3. Agarwal B, Bhendwal S, Ramey WG, Halmos B, Moss SF, Holt PR. Lovastatin sensitizes colon cancer cells to apoptosis induced by chemotherapeutic agents. Clinical Cancer Research 1999;5:2223-2229. 4. Agarwal B, Rao CV, Bhendwal S, Ramey WR, Shirin H, Reddy BS, Holt Holt. Lovastatin augments sulindac induced apoptosis in colon cancer cells and potentiates the chemopreventive effect of Sulindac in AOM model of colon carcinogenesis. Gastroenterology 1999;117:838-847. 5. Agarwal B, Halmos B, Feoktistov A, Protiva P, Pothoulakis C, Chen M, Lamont JT, Holt PR. Lovastatin-induced apoptosis is not related to the membrane translocation rho. Carcinogenesis 2002;23:521-528. 6. Farrell R, Agarwal B, Brandwein S, Underhill J, Chuttani R, Pleskow DK. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures. Gastrointestinal Endoscopy. 2002;56:681-687. 7. Agarwal B, Swaroop P, Protiva P, Raj SV, Shirin H, Holt PR. Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells. Apoptosis. 2003;8:649-654. 8. Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. American Journal of Gastroenterology 2004;99:844-850. 9. Agarwal B, Kuehn S, Collins BT. Dilated pancreatic duct and common bile duct in a patient with abdominal pain and weight loss. American Journal of Gastroenterology 2004;99:16231624. 10. Agarwal B, Swisher S, Kelly K, Lynch P, Ajani J, Komaki RR, Putnam JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Kelly J, Liao Z, Rice DC, Smythe RW, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. American Journal of Gastroenterology 2004;99:1258-1266. 11. Agarwal B, Swisher S, Kelly K, Ho L, Ajani J, Lynch P, Vaporcyian AC, Walsh G, Putnam JB, Roth J. Differential response to pre-operative chemoradiation and surgery in esophageal adenocarcinoma patients based on presence of Barrett’s esophagus or symptomatic GERD.

Banke Agarwal, M.D. Annals of Thoracic Surgery 2005;79:1716-1723.

6

12. Agarwal B, Gogia S, Eloubeidi MA, Correa AM, Ho L, Collins BT. Malignant mediastinal lymphadenopathy detected by staging EUS in patients with pancreaticobiliary cancer. Gastrointestinal Endoscopy 2005;61:849-853. 13. Memisoglu E, Agarwal B, Akduman I, Prather CM, Collins BT, Civelek C. Multimodality diagnostic imaging of diffuse esophageal leiomyomatosis. Journal of Computer Assisted Tomography. 2006;30:100-4. 14. Krishna NB, Gardner G, Collins BT, Agarwal B. Periportal lymphadenopathy in patients without identifiable pancreatobiliary or hepatic malignancy. Clinical Gastroenterology and Hepatology. 2006;4:1373-7. 15. Krishna NB, Saripalli S, Safdar R, Agarwal B. Intraductal Ultrasound in the evaluation of biliary strictures without an identifiable mass lesion on CT or MRI: significance of focal wall thickening and extrinsic compression at the stricture site. Gastrointestinal Endoscopy 2007;66:90-6. 16. Agarwal B, Correa AM, Ho L. Survival in Pancreatic Carcinoma Based on Tumor Size. Pancreas 2008, e15-e20. 17. Agarwal B, Labundy JL, Krishna NB, Rizwan Safdar Akduman I. EUS/EUS-FNA in patients with CT/MRI findings of enlarged pancreatic head or dilated pancreatic duct ± dilated common bile duct. Gastrointestinal Endoscopy (in press). 18. Agarwal B, Krishna NB, Labundy JL, Safdar R, Saripalli S. Diagnostic Value of EUS/EUSFNA in suspected pancreatic cancer patients with focal lesion on CT/MRI but without obstructive jaundice. Submitted. 19. Nahel Saied, Ashish Chopra, Barugur Ravi, Stefan Ianchulev, Banke Agarwal. Parenteral Erythromycin Rapidly Empties Gastric Contents Retained after Overnight Pre-operative Fasting. Submitted. 20. Banke Agarwal, Olivia Ludwig, Brian T. Collins, Cherise Cortese. Immunostaining as an adjunct to cytologic assessment of endoscopic ultrasound guided fine needle aspiration (EUSFNA) specimens for diagnosis of pancreatic adenocarcinoma. Submitted.

Book Chapters and Reviews: 1.

Agarwal B, Protiva P. Endoscopic ultrasonography in the diagnosis of pancreatic and periampullary neoplasms. International Journal of Gastrointestinal Cancer 30:33-45, 2001.

2.

Agarwal B. Endoscopy in the management of gastrointestinal malignancies. In: Ajani JA, Curley SA, Janjan NA, Lynch PM, eds. Gastrointestinal Cancer. New York: Springer Science + Business Media, Inc; 2005;43-57.

3.

Banke Agarwal, M.D. Mohit Mehra and Banke Agarwal. Endoscopic Diagnosis and Staging of MALT 7 lymphoma. Current Opinion in Gastroenterology. In press.

Abstracts: 1. Agarwal B, Mehta P, Saluja S, Sethuraman KR. Erythromycin ameliorates abnormal gall bladder contraction in diabetic autonomic neuropathy. Gastroenterology 1995;108:404. 2. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Helicobacter pylori infection induces gastric epithelial apoptosis in vivo. Gastroenterology 1995;108:A741. 3. Agarwal B, Halmos B, Ramey WG, Moss SF, Holt PR. Lovastatin induced apoptosis and morphological changes in IEC-18 cells are inhibited by cycloheximide. Gastroenterology 1998;114:G2486. 4. Agarwal B, Halmos B, Bhendwal S, Ramey WG, Moss SF, Holt PR. Lovastatin induced apoptosis in intestinal epithelial cells is independent of ras and is reversed by geranylgeraniol. Gastroenterology 1998;114:G2268. 5. Halmos B, Agarwal B, Moss SM, Ramey WG, Holt PR. Lovastatin causes p53 dependent apoptosis in intestinal IEC-18 cell lines. Proceedings of the American Association of Cancer Research, 1998;39:574. 6. Agarwal B, Halmos B, Moss SF, Ramey WG, Holt PR. Lovastatin sensitizes colon cancer HT-29 cells to apoptosis induced by chemotherapeutic agents. Proceedings of the American Association of Cancer Research 1998;39:68. 7. Feoktistov AS, Agarwal B, Halmos B, Swaroop P, Chen M, Pothoulakis H, Lamont TJ, Holt PR. Inhibition of membrane localization of Rho is not sufficient to explain lovastatin induced apoptosis. Proceedings of the American Association of Cancer Research 1999;40:57. 8. Agarwal B, Halmos B, Protiva P, Swaroop P, Bhendwal S, Shirin H, Ramey WR, Holt PR. Sodium Phenylacetate inhibits proliferation and induces apoptosis in intestinal epithelial cells by mechanisms other than inhibition of isoprenylation. Proceedings of the American Association of Cancer Research 1999;40:582. 9. Agarwal B, Rao CV, Bhendwal S, Ramey WR, Shirin H, Reddy BS, Holt PR. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effect of sulindac. Proceedings of the American Association of Cancer Research 1999:40:57. 10. Feoktistov AS, Agarwal B, Halmos B, Swaroop P, Bhendwal S, Ramey WR, Cheng M, Pothoulakis C, Lamont JT, Holt PR. Inhibition of membrane localization of Rho is not sufficient to explain lovastatin induced apoptosis. Gastroenterology 1999;116:G1764. 11. Agarwal B, Protiva P, Swaroop P, Bhendwal S, Halmos B, Ramey WR, Shirin S, Holt PR. Sodium Phenylacetate inhibits proliferation and induces apoptosis in intestinal epithelial cells by mechanisms other than inhibition of isoprenylation. Gastroenterology 1999;116:G1616.

Banke Agarwal, M.D. 12. Agarwal B, Swaroop S, Protiva P, Bhendwal S. Ramey WR, Shirin J, Feoktistov AS, Holt 8 PR. Sulindac sulfide induces apoptosis by both Cox-2 dependent and Cox-2 independent mechanisms and inhibits proliferation by a Cox-2 independent mechanism. Gastroenterology 1999;116:G1615. 13. Agarwal B, Feoktistov AS, Swaroop P, Bhendwal S, Protiva P, Ramey WR, Cheng M, Pothoulakis C, Lamont JT, Holt PR. Lovastatin induced apoptosis correlates with increase in cytosolic Cdc42. Gastroenterology 1999;116:G1614. 14. Zakai MD, Snady H, Paradiso H, Agarwal B. Accurate diagnosis of gastrointestinal (GI) submucosal lesions with endoscopic ultrasound and histology. American Journal of Gastroenterology 2000;95:2644. 15. Agarwal B, Swaroop S, Protiva P, Chuttani R, Holt PR. Cox-2 selective inhibitors induce apoptosis by Cox-2 dependent and Cox-2 independent mechanisms. Gastroenterology, 2000;118:A52. 16. Agarwal B, Protiva P, Swaroop P, Chuttani R, Ramey WR, Holt PR. Lovastatin augments apoptosis induced by Cox-2 selective inhibitors in colon cancer cells. Gastroenterology, 2000;118:A681. 17. Protiva P, Agarwal B, Delahory T, Holt PR. Phenylacetate augments chemotharapeutic induced apoptosis in colon cancer cells. Gastroenterology, 2001;120:A616. 18. Yao JC, Najam AA, Rashid A, Lynch P, Gagneja H, Agarwal B, Giacco G, Putnam J, Swisher SJ, Roth J, Ajani J. Clinical and pathologic features of patients with carcinoma associated with Barrett’s metaplasia: an analysis of 1162 patients with esophageal or esophagogastric junction cancer. ASCO 2002;538. 19. Farrell R, Agarwal B, Brandwein S, Underhill J, Chuttani R, Pleskow D. Intraductal Ultrasound Is a useful adjunct to ERCP in distinguishing malignant from benign biliary strictures. Gastroenterology 2002;122:P177. 20. Agarwal B, Swisher S, Kelly K, Ajani J, Komaki RU, Putnam JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens WR, Vaporciyan AA, Yao J, Roth JA. Determinants of response to chemoradiation in patients with esophageal cancer. Gastroenterology 2002;122:A351. 21. Agarwal B, Bismar MM, Protiva P, Molke KL, Lehmann J, Ho L, Fanning C, Sneige N, Weiser MA, Charnsangavej C, Abbruzzesse J. EUS/FNA in the diagnosis of pancreatic neoplasms: comparison with spiral CT. Gastroenterology 2002;122:P282. 22. Agarwal B, Swisher S, Kelly K, Lynch P, Ajani J, Komaki RR, Putnam JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Kelly J, Liao Z, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Role of EUS lymph node assessment after pre-operative chemoXRT in esophageal cancer patients. Gastroenterology 2002;122:P279.

Banke Agarwal, M.D. 23. Protiva P, Agarwal B, Shimizu M, Weinstein IB, Holt P. Phenylacetate induces GI/S arrest 9 and apoptosis in colon cancer cells but antagonizes S-phase specific chemotherapy. Gastroenterology 2003;124:A463. 24. Agarwal B, Swisher S, Kelly K, Ajani J, Komaki RR, Putnam, Jr. JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Pre-operative chemoradiation downstages esophageal adenocarcinoma and abolishes differences in post-operative survival between T3N0 and T3N1 esophageal cancers. Gastroenterology 2003;124:A652. 25. Gogia S, Bismar M, Collins BT, Correa AM, Ho L, Agarwal B. Is it worthwhile to evaluate pancreas in patients undergoing staging EUS for esophageal cancer? Gastrointestinal Endoscopy 2004;59:AB215. 26. Banke Agarwal, Gogia S, Correa AM, Ho L, Collins BT. Malignant mediastinal lymphadenopathy in patients with pancreatobiliary cancer. Gastrointestinal Endoscopy 2004;59:AB224. 27. Agarwal B, Bismar M, Gogia S, Ho L, Correa AM, Collins BT. Pre-operative identification of malignancy in cystic lesions of the pancreas by EUS-FNA. Gastrointestinal Endoscopy 2004;59:AB229. 28. Gogia S, Swaroop P, Agarwal B. Significance of diminutive colonic polyps. Gastrointestinal Endoscopy 2005;62:AB246. 29. Krishna NB, Collins BT, Agarwal B. Differential diagnosis of enlarged periportal lymph nodes in patients without pancreatobiliary malignancies. Gastrointestinal Endoscopy 2005;62:AB268. 30. Agarwal B, Correa AM, Ho L. How early should pancreatic cancer be diagnosed to significantly improve survival? Gastrointestinal Endoscopy 2005;62:AB268. 31. Naveen B. Krishna, Saradhi Saripalli, Banke Agarwal. Clinical Value of EUS/EUS-FNA in evaluation of patients with abnormal pancreas on CT scan but without history of obstructive jaundice. Gastrointestinal Endoscopy 2006;63:AB269 32. Naveen B. Krishna, Saradhi Saripalli, Rizwan Safdar, Banke Agarwal . IDUS in evaluation of biliary strictures without a mass lesion on CT scan: significance of focal wall thickening and extrinsic compression at the stricture site. Gastrointestinal Endoscopy 2006;63:AB258 33. Saradhi Saripalli, Naveen B. Krishna, Rizwan Safdar, Banke Agarwal Patients with obstructive jaundice and abnormal imaging: Role of EUS/EUS-FNA in management. Gastrointestinal Endoscopy 2006;63:AB274 34. Olivia Ison, Cherise Cortese, Brian Collins, Sara McKenzie, Naveen B. Krishna, Banke Agarwal. Immunostaining as an Adjunct to Cytologic Assessment of Endoscopic Ultrasound Guided Fine Needle Aspiration (EUS-FNA) Specimens for the Diagnosis of Pancreatic Adenocarcinoma. Selected for presentation at the American Society of Clinical Pathologists meeting in Las Vegas, October 18-22, 2006.

Banke Agarwal, M.D. 35. Nahel Saied, Barugar Ravi, Stefan Ianchulev, Banke Agarwal. Parenteral Erythromycin Rapidly Empties Retained Gastric Contents: Potential Role in Outpatient Procedures in the Endoscopy unit. DDW 2007.

10

36. Banke Agarwal, Jennifer LaBundy, Naveen Krishna, Brian T. Collins. Endoscopic ultrasound guided fine needle aspiration biopsy for diagnostic evaluation of proximal biliary strictures. DDW 2007. 37. Olivia Ludwig, Cherise Cortese, Brian T. Collins, Banke Agarwal. Immunostaining as adjunct to cytologic assessment of endoscopic ultrasound guided fine needle aspiration (EUS-FNA) specimens for diagnosis of pancreatic adenocarcinoma. DDW 2007. 38. Banke Agarwal, Amit V. Reddy, Jennifer L. Labundy, Naveen Krishna. Diagnostic accuracy of EUS-FNA for pancreatic cancer in patients with or without associated chronic pancreatitis. DDW 2008 39. Banke Agarwal, Amit V. Reddy, Jennifer L. Labundy, Naveen Krishna Clinical significance of dilated common bile duct and pancreatic duct in patients with or without obstructive jaundice. DDW 2008

L. CURRENT AND PAST TECHING RESPONSIBILITIES 2002 – Present

Saint Louis University School of Medicine teaching subspecialty residents in gastroenterology, internal medicine house staff, and students

N. SUPPLEMENTAL MATERIAL: INVITED PRESENTATIONS 1. “Lovastatin and the colon”, Invited speaker, Columbia Presbyterian Medical Center, Columbia University, New York. September, 1997. 2. “HMG-CoA reductase inhibitors and colonic epithelial cells.” Invited speaker, All India Institute of Medical Sciences, New Delhi, India, February, 1998. 3. “Effect of lovastatin and colon epithelial cells- potential role for chemoprevention of colon cancer.” Invited speaker, Columbia Cancer Center, Columbia University, New York, NY, April, 1998. 4. “Lovastatin induced apoptosis and morphological changes in IEC-18 cells are inhibited by cycloheximide.” Presented at the American Gastroenterological Association, New Orleans, LA, 1998.

Banke Agarwal, M.D. 5. “Lovastatin induces apoptosis and sensitizes colon cancer cells to apoptosis induced by 11 chemotherapeutic agents.” Presented at Young Investigators Conference, Santa Monica, CA, April, 2998. 6. “Lovastatin sensitizes HT-29 colon cancer cells to apoptosis induced by chemotherapeutic agents.” Presented the annual meeting of the American Gastroenterological Association, Tampa Florida, March, 1998. 7. “Cox-2 inhibition and chemoprevention of colon cancer.” Invited speaker, Columbia Cancer Center, Columbia University, New York, NY, January, 1999. 8. “Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates it chemopreventive effect on colon cancer.” Presented at Gastro 99, Vancouver, Canada, 1999. 9. “Phenylacetate induces growth arrest and apoptosis in intestinal epithelial cells by mechanism independent of inhibition of isoprenylation.” Presented the annual meeting of the American Gastroenterological Association, Orlando, FL, May, 1999. 10. “Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates the chemopreventive effect of sulindac.” Presented at Young Investigators Conference, Atlanta, GA, April, 1999. 11. Lovastatin augments apoptosis induced by Cox-2 selective inhibitors in colon cancer cells.” Podium presentation at the Young Investigator’s Conference, La Jolla, CA, April, 2000. 12. “Role of EUS in diagnosis of pancreatic cancer.” Invited speaker, All India Institute of Medical Sciences, New Delhi, India, January, 2001. 13. “Diagnosis of biliary strictures.” Invited speaker, MD Anderson Cancer Center, Houston, TX, January 2001. 14. “Lovastatin and Colon Cancer.” Invited speaker, University Texas Medical Branch, Galveston, TX, March, 2001. 15. “Statins in the chemoprevention and treatment of colon cancer.” Invited speaker, Tulane University School of Medicine, New Orleans, Louisiana, April, 2001. 16. “Colon cancer: Newer strategies.” Invited speaker, University of Texas, Houston, TX, May, 2001. 17. “Chemoprevention of colon cancer.” St. Luke’s Roosevelt Hospital Center, Columbia University, New York, NY, May, 2001. 18. “Diagnosis of gastropancreatic endocrine tumors.” Invited speaker, general session, Annual meeting of the American Society of Clinical Endocrinologist, San Antonio, TX, May, 2001. 19. “Esophagoscopy and endoscopic ultrasonography.” Invited speaker, Baylor College of Medicine, Houston, TX, September, 2001.

Banke Agarwal, M.D. 20. “Endoscopic ultrasound in the diagnosis and staging of gastrointestinal cancers.” Invited 12 speaker, Annual Scientific meeting of the American Society of Cytopathology, Kansas City, KS, November, 2001. 21. “Esophageal adenocarcinoma: determinants of response to chemoradiation and role of EUS.” Invited speaker, Apollo Hospitals, New Delhi, India, February, 2002. 22. “Esophageal adenocarcinoma: determinants of response to chemoradiation and role of EUS.” Invited speaker, Dayanand Medical College, Ludhiana, India, February, 2002. 23. “Statins- looking beyond the heart.” Invited speaker, Fortis Heart Institute. Chandigarh, India, February, 2002. 24. “EUS in the diagnosis and management of GI disease.” Saint Louis University Division of Gastroenterology and Hepatology Spring Symposium. St. Louis, MO, March, 2002. 25. “Advances in Diagnosis of Pancreatic Cancer.” Invited speaker, Forest Park Hospital, St. Louis, MO, August, 2002. 26. “EUS- how it can help you?” Invited speaker, Saint Louis University Department of Internal Medicine Grand Rounds, St. Louis, MO August, 2002. 27. “EUS-FNA in the diagnosis and staging of pancreatic cancer.” Invited speaker, Saint Louis University Gastrointestinal Cancers: Integrating recent advances into Clinical Practice, St. Louis, MO October, 2002. 28. “Role of EUS in patients with suspected or proven gastrointestinal cancers: Invited speaker, University of Missouri, Columbia, MO, July, 2003. 29. “Endoscopic ultrasound in gastrointestinal cancers”, Invited speaker, The Boone Clinic, Columbia, MO, February, 2004. 30. Visiting professor to Division of Gastroenterology, St. Luke’s-Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, NY. February 2005. 31. EUS in diagnosis and management of gastrointestinal cancers. Invited speaker to GUT club, Decatur, IL. May 2005. 32. Endoscopic Ultrasound: How it can help your patients. Invited speaker for Internal Medicine Grand Rounds at Southern Illinois University, Springfield, IL. April 25, 2006. 33. EUS- How can it help you in your clinical practice. Invited speaker to Division of Gastroenterology, St. John’s Hospital, Springfield, MO. July 19, 2006. 34. EUS in the diagnostic evaluation of patients with suspected pancreatobiliary cancers: GI Grand Rounds at the University of Nebraska Medical Center, Omaha, NE. August 14, 2006. 35. EUS in the diagnosis and management of pancreatobiliary tumors. Invited speaker to Division of Gastroenterology, Boone Clinic, Columbia, MO. Sept. 20, 2006.

Banke Agarwal, M.D. 36. EUS- How can it help you in your clinical practice. Invited speaker to SGNA symposium 2006, Normal, IL. Nov 11, 2006.

13